Ready-to-use injectable medicines require no further dilution or reconstitution before transfer to an administration device. For example, a sterile liquid medicine in a glass vial, in the required concentration, only needs to be drawn up into a syringe and therefore reduces the potential for errors to occur. They can also reduce the possibility of particle infiltration and contamination.
Advantages of ready-to-use solutions:
• delivery of the right drug in the right concentration and in the right presentation
• reducing risk of medication errors
• reducing risk of contamination
• improving patient safety
• reducing workload for nursing staff, releasing time for patient care
With a keen focus on patient safety, hameln has developed a range of Ready-to-Use products which help minimise risks when preparing and administering injectable medicines. These products are supplied in easy to store 50 ml vials for use in intensive care units, and are available in drug infusion concentrations in line with the Intensive Care Society’s recommendations on standard medication infusion concentrations in critical care areas1:
1 Infusion medication concentrations in UK’s critical care areas: Are the Intensive Care Society’s recommendations being used? Titiesari Y, Barton G, Borthwick M, Keeling S, Keeling P. J Intensive Care Soc 2017, Vol. 18(1) 30–35
hameln is a leading supplier of high quality generic injectable medicines, specialising in critical care. Our portfolio contains a variety of products, ranging from water for injections to sedatives, anaesthetics, analgesics and antidotes. Everything we do is driven by the understanding we are all patients.